Table: Kobayashi Pharmaceutical - 6-MTH group results

Kobayashi Pharmaceutical

06/08/2026 07:34

    Aug 6 (Reuters)- 
             Kobayashi Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Jun 30, 2026        Jun 30, 2025     Dec 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             70.75               69.02           173.00    
                 (+2.5 pct)          (-5.6 pct)       (+4.4 pct)  
  Operating          2.16                6.65            12.50    
                 (-67.5 pct)         (-29.8 pct)      (-16.2 pct) 
  Recurring          3.01                7.25            13.00    
                 (-58.5 pct)         (-30.6 pct)      (-23.5 pct) 
  Net                1.14                3.17            10.00    
                 (-64.1 pct)        (+120.5 pct)     (+173.5 pct) 
  EPS             15.29 yen           42.61 yen       134.52 yen  
  Ann Div                            104.00 yen       106.00 yen  
  -Q2 div         45.00 yen           44.00 yen                   
  -Q4 div                             60.00 yen        61.00 yen  
  
  NOTE - Kobayashi Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T